Show simple item record

dc.contributor.authorBouza, Carmen 
dc.contributor.authorLopez-Cuadrado, Teresa 
dc.contributor.authorAmate, Jose Maria 
dc.date.accessioned2020-03-04T12:01:12Z
dc.date.available2020-03-04T12:01:12Z
dc.date.issued2016-10-03
dc.identifier.citationCrit Care. 2016 Oct 3;20(1):313.es_ES
dc.identifier.issn1364-8535es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/9170
dc.description.abstractBACKGROUND: Severe sepsis is a challenge for healthcare systems, and epidemiological studies are essential to assess its burden and trends. However, there is no consensus on which coding strategy should be used to reliably identify severe sepsis. This study assesses the use of explicit codes to define severe sepsis and the impacts of this on the incidence and in-hospital mortality rates. METHODS: We examined episodes of severe sepsis in adults aged ≥18 years registered in the 2006-2011 national hospital discharge database, identified in an exclusive manner by two ICD-9-CM coding strategies: (1) those assigned explicit ICD-9-CM codes (995.92, 785.52); and (2) those assigned combined ICD-9-CM infection and organ dysfunction codes according to modified Martin criteria. The coding strategies were compared in terms of the populations they defined and their relative implementation. Trends were assessed using Joinpoint regression models and expressed as annual percentage change (APC). RESULTS: Of 222 846 episodes of severe sepsis identified, 138 517 (62.2 %) were assigned explicit codes and 84 329 (37.8 %) combination codes; incidence rates were 60.6 and 36.9 cases per 100 000 inhabitants, respectively. Despite similar demographic characteristics, cases identified by explicit codes involved fewer comorbidities, fewer registered pathogens, greater extent of organ dysfunction (two or more organs affected in 60 % versus 26 % of cases) and higher in-hospital mortality (54.5 % versus 29 %; risk ratio 1.86, 95 % CI 1.83, 1.88). Between 2006 and 2011, explicit codes were increasingly implemented. Standardised incidence rates in this cohort increased over time with an APC of 12.3 % (95 % CI 4.4, 20.8); in the combination code cohort, rates increased by 3.8 % (95 % CI 1.3, 6.3). A decreasing trend in mortality was observed in both cohorts though the APC was -8.1 % (95 % CI -10.4, -5.7) in the combination code cohort and -3.5 % (95 % CI -3.9, -3.2) in the explicit code cohort. CONCLUSIONS: Our findings suggest greater and increasing use of explicit codes for adult severe sepsis in Spain. This trend will have substantial impacts on epidemiological estimates, because these codes capture cases featuring greater organ dysfunction and in-hospital mortality.es_ES
dc.description.sponsorshipFunding was provided by the Spanish National I + D Programme (grant number STPY 1346/09). The funding body had no further role in study design, data collection, analysis, interpretation, writing of the report or the decision to submit the paper for publication.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEpidemiologyes_ES
dc.subjectHealth services researches_ES
dc.subjectIncidencees_ES
dc.subjectOutcomees_ES
dc.subjectSevere sepsises_ES
dc.subjectTrendses_ES
dc.subject.meshAged es_ES
dc.subject.meshCohort Studies es_ES
dc.subject.meshEpidemiologic Studies es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHumans es_ES
dc.subject.meshIncidence es_ES
dc.subject.meshInternational Classification of Diseases es_ES
dc.subject.meshMale es_ES
dc.subject.meshMiddle Aged es_ES
dc.subject.meshSepsis es_ES
dc.subject.meshSpain es_ES
dc.titleUse of explicit ICD9-CM codes to identify adult severe sepsis: impacts on epidemiological estimateses_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID27716355es_ES
dc.format.volume20es_ES
dc.format.number1es_ES
dc.format.page313es_ES
dc.identifier.doi10.1186/s13054-016-1497-9es_ES
dc.contributor.funderMinisterio de Sanidad, Servicios Sociales e Igualdad (España) 
dc.description.peerreviewedes_ES
dc.identifier.e-issn1466-609Xes_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s13054-016-1497-9es_ES
dc.identifier.journalCritical care (London, England)es_ES
dc.repisalud.centroISCIII::Agencia de Evaluación de Tecnologías Sanitariases_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/STPY 1346/09es_ES
dc.rights.accessRightsopen accesses_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This item is licensed under a: Atribución 4.0 Internacional